Cargando…

Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial

BACKGROUND: Surgical site infection (SSI) is a common complication following abdominal surgery. It is associated with considerable morbidity and mortality, and its management results in significant cost to health services within both primary and secondary care. Some surgeons believe that the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinkney, Thomas D, Bartlett, David C, Hawkins, William, Mak, Tony, Youssef, Haney, Futaba, Kaori, Harrison, Gareth, Gheorghe, Adrian, Bradbury, Jennifer M, Calvert, Melanie J, Dowswell, George, Magill, Laura, Redman, Val, Wilson, Sue, Leaper, David, Morton, Dion G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201898/
https://www.ncbi.nlm.nih.gov/pubmed/21970469
http://dx.doi.org/10.1186/1745-6215-12-217
_version_ 1782214936752029696
author Pinkney, Thomas D
Bartlett, David C
Hawkins, William
Mak, Tony
Youssef, Haney
Futaba, Kaori
Harrison, Gareth
Gheorghe, Adrian
Bradbury, Jennifer M
Calvert, Melanie J
Dowswell, George
Magill, Laura
Redman, Val
Wilson, Sue
Leaper, David
Morton, Dion G
author_facet Pinkney, Thomas D
Bartlett, David C
Hawkins, William
Mak, Tony
Youssef, Haney
Futaba, Kaori
Harrison, Gareth
Gheorghe, Adrian
Bradbury, Jennifer M
Calvert, Melanie J
Dowswell, George
Magill, Laura
Redman, Val
Wilson, Sue
Leaper, David
Morton, Dion G
author_sort Pinkney, Thomas D
collection PubMed
description BACKGROUND: Surgical site infection (SSI) is a common complication following abdominal surgery. It is associated with considerable morbidity and mortality, and its management results in significant cost to health services within both primary and secondary care. Some surgeons believe that the use of a wound-edge protection device may reduce the incidence of SSI. Whilst there is some encouraging evidence showing that such devices may lead to a reduction in SSI, there are no controlled trials of sufficient size or quality to support their routine use. METHODS/DESIGN: 750 patients will be recruited from around 20 surgical units within the United Kingdom. Patients undergoing laparotomy through any major abdominal incision for any indication, elective or emergency, are eligible. Patients under the age of 18, those undergoing a laparoscopic assisted procedure or who have undergone laparotomy within the previous 3 months, and those who are unable to give informed consent will be excluded. Patients will be randomised (1:1 ratio) to the use of a wound-edge protection device or no wound-edge protection device during surgery. Follow up will consist of blinded clinical wound reviews at 5-7 days and 30-33 days postoperatively with a self-completed questionnaire covering the intervening period. Quality of life questionnaires will be completed prior to surgery and at the subsequent wound review points and information on resource usage will also be captured. The primary outcome measure is SSI within 30 days of surgery. Secondary outcomes include the impact of the degree of wound contamination, patient comorbidity, and operative characteristics on the efficacy of a wound-edge protection device in reducing SSI and whether the use of a wound-edge protection device has an effect on health-related quality of life or length of hospital stay and is cost-effective. DISCUSSION: Rossini is the first multicentre observer-blinded randomised controlled trial of sufficient size and quality to establish whether the use of a wound-edge protection device in adult patients undergoing abdominal surgery leads to a lower rate of SSI. The results of this study will be used to inform current surgical practice and may potentially benefit patients undergoing surgery in the future. TRIAL REGISTRATION NUMBER: Current Controlled Trials ISRCTN: ISRCTN40402832
format Online
Article
Text
id pubmed-3201898
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32018982011-10-26 Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial Pinkney, Thomas D Bartlett, David C Hawkins, William Mak, Tony Youssef, Haney Futaba, Kaori Harrison, Gareth Gheorghe, Adrian Bradbury, Jennifer M Calvert, Melanie J Dowswell, George Magill, Laura Redman, Val Wilson, Sue Leaper, David Morton, Dion G Trials Study Protocol BACKGROUND: Surgical site infection (SSI) is a common complication following abdominal surgery. It is associated with considerable morbidity and mortality, and its management results in significant cost to health services within both primary and secondary care. Some surgeons believe that the use of a wound-edge protection device may reduce the incidence of SSI. Whilst there is some encouraging evidence showing that such devices may lead to a reduction in SSI, there are no controlled trials of sufficient size or quality to support their routine use. METHODS/DESIGN: 750 patients will be recruited from around 20 surgical units within the United Kingdom. Patients undergoing laparotomy through any major abdominal incision for any indication, elective or emergency, are eligible. Patients under the age of 18, those undergoing a laparoscopic assisted procedure or who have undergone laparotomy within the previous 3 months, and those who are unable to give informed consent will be excluded. Patients will be randomised (1:1 ratio) to the use of a wound-edge protection device or no wound-edge protection device during surgery. Follow up will consist of blinded clinical wound reviews at 5-7 days and 30-33 days postoperatively with a self-completed questionnaire covering the intervening period. Quality of life questionnaires will be completed prior to surgery and at the subsequent wound review points and information on resource usage will also be captured. The primary outcome measure is SSI within 30 days of surgery. Secondary outcomes include the impact of the degree of wound contamination, patient comorbidity, and operative characteristics on the efficacy of a wound-edge protection device in reducing SSI and whether the use of a wound-edge protection device has an effect on health-related quality of life or length of hospital stay and is cost-effective. DISCUSSION: Rossini is the first multicentre observer-blinded randomised controlled trial of sufficient size and quality to establish whether the use of a wound-edge protection device in adult patients undergoing abdominal surgery leads to a lower rate of SSI. The results of this study will be used to inform current surgical practice and may potentially benefit patients undergoing surgery in the future. TRIAL REGISTRATION NUMBER: Current Controlled Trials ISRCTN: ISRCTN40402832 BioMed Central 2011-10-04 /pmc/articles/PMC3201898/ /pubmed/21970469 http://dx.doi.org/10.1186/1745-6215-12-217 Text en Copyright ©2011 Pinkney et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Pinkney, Thomas D
Bartlett, David C
Hawkins, William
Mak, Tony
Youssef, Haney
Futaba, Kaori
Harrison, Gareth
Gheorghe, Adrian
Bradbury, Jennifer M
Calvert, Melanie J
Dowswell, George
Magill, Laura
Redman, Val
Wilson, Sue
Leaper, David
Morton, Dion G
Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial
title Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial
title_full Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial
title_fullStr Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial
title_full_unstemmed Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial
title_short Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial
title_sort reduction of surgical site infection using a novel intervention (rossini): study protocol for a randomised controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201898/
https://www.ncbi.nlm.nih.gov/pubmed/21970469
http://dx.doi.org/10.1186/1745-6215-12-217
work_keys_str_mv AT pinkneythomasd reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT bartlettdavidc reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT hawkinswilliam reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT maktony reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT youssefhaney reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT futabakaori reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT harrisongareth reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT gheorgheadrian reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT bradburyjenniferm reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT calvertmelaniej reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT dowswellgeorge reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT magilllaura reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT redmanval reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT wilsonsue reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT leaperdavid reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial
AT mortondiong reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial